Title not supplied

The

JAMA 1975

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

AUTHOR UNKNOWN

Br Heart J, (10):1069-1118 1978

MED: 361054

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V

N Engl J Med, (20):1237-1245 1987

MED: 3313041

Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with type IIA or IIB hyperlipidemia.

Brown WV, Dujovne CA, Farquhar JW, Feldman EB, Grundy SM, Knopp RH, Lasser NL, Mellies MJ, Palmer RH, Samuel P

Arteriosclerosis, (6):670-678 1986

MED: 3535757

Influence of probucol on cholesterol and lipoprotein metabolism in man.

Kesaniemi YA, Grundy SM

J Lipid Res, (8):780-790 1984

MED: 6491523

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.

Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C

Proc Natl Acad Sci U S A, (16):5928-5931 1987

MED: 3475709

Title not supplied

The

Arch Intern Med 1988

Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.

Grundy SM, Mok HY

J Lab Clin Med, (2):354-366 1977

MED: 833472

Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.

Kane JP, Malloy MJ, Tun P, Phillips NR, Freedman DD, Williams ML, Rowe JS, Havel RJ

N Engl J Med, (5):251-258 1981

MED: 7003391

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L

JAMA, (23):3233-3240 1987

MED: 3295315